Articles tagged with Cancer Patients
Research at Fred Hutchinson Cancer Center found that patients face structural and clinical barriers to participating in clinical trials, with nearly 22% deemed ineligible. The team calls for policy changes such as expanding trial locations and proactively discussing options with patients to increase access and participation.
Research reveals that patients with specific MAPK mutations are more likely to respond to immunotherapy drugs in glioblastoma. The study also found that tumors with PTEN mutations were less responsive to treatment, suggesting new targets for treatment development.
A research team at the Medical University of South Carolina has discovered a novel binding site for E1 inhibitors, which could lead to the design of more efficient anti-cancer drugs. The study reveals a new mechanism for promoting drug design and specificity.
A novel mobile application called MyPath uses AI to provide personalized guidance and support to breast cancer patients in rural Georgia. The app adapts to each stage of a patient's journey, offering relevant resources and suggestions based on their medical data and changing needs.
A new study found that kidney failure patients on dialysis and transplants have significantly higher risks of dying from cancer than the general population. Cancer deaths were mainly driven by cancers present prior to dialysis or arising after transplantation, particularly those related to immune deficiency and viral infection.
Researchers discovered that BRAF inhibitors render resistant melanoma cells more sensitive to T cell attack by increasing the expression of a protein called M6PR. This finding suggests that adoptive T cell therapy may be therapeutically useful for patients who have become resistant to BRAF inhibitors.
A new study suggests that recurring infections could lead to delayed diagnoses of bladder or kidney cancer in women. Analysis of over 100,000 people found that many with blood in their urine had no check-up after initial UTI symptoms.
Two clinical studies show that liquid biopsies can accurately track lung cancer treatment responses, detecting changes in circulating tumor DNA four weeks earlier than CT imaging. The tests provide a more accurate and noninvasive way to assess therapeutic responses, avoiding unneeded toxicity or ineffective treatments.
A Dartmouth research team has found a machine learning method to predict atypical ductal hyperplasia (ADH) upgrade to cancer. The model identifies 98% of all malignant cases prior to surgery while sparing 16% of women who would have undergone unnecessary surgery for a benign lesion.
Researchers have developed a new imaging and platelet targeting chemotherapy agent for early detection and treatment of cancers. The approach holds promise for diagnosing and treating tumors without major side effects.
A new cancer drug called tisotumab vedotin has shown significant promise in treating various types of cancer, with a response rate of up to 27% in patients with advanced, drug-resistant cancers. The treatment works by releasing a toxic substance to kill cancer cells from within and has manageable side effects.
A study led by Johns Hopkins Medicine found that immunotherapy drug pembrolizumab is more effective than traditional chemotherapy for patients with aggressive Merkel cell carcinoma. The treatment showed high response rates and durable progression-free survival in both virus-positive and virus-negative subtypes.
Researchers at Georgetown Lombardi Comprehensive Cancer Center found that immunotherapy checkpoint inhibitors are both safe and effective in treating advanced cancer patients with HIV. The therapy offers similar objective response rates as non-infected patients, with benefit also seen in Kaposi's sarcoma treatment.
A recent increase in vocal-cord cancer diagnoses among young adults, mostly non-smokers, is attributed to human papilloma virus (HPV) infection. HPV-associated strains are found in all tested samples of vocal-cord cancer from patients under 30, greatly resembling recurrent respiratory papillomatosis.
A new review highlights the need for targeted approaches to address cancer therapies' impact on bone health. Efforts to limit these effects have largely relied on anti-resorptive agents with limited assessment of fracture risk reduction.
Researchers found implicit bias and mistrust issues leading to reduced treatment rates for black patients. A new system-based intervention eliminated disparities by providing real-time transparency and enhanced patient-centered communication.
A new study published in Pediatric Blood and Cancer found that early cancer surveillance in patients with Li-Fraumeni Syndrome is cost-effective, resulting in additional years of life. The research showed a significant increase in life expectancy for high-risk patients, with healthcare costs estimated at $17,000 per year gained.
Cancer researchers have mapped oesophageal adenocarcinoma genes in unprecedented detail, unveiling more than half as potentially targetable by drugs already in trials for other cancers. This breakthrough could lead to personalized therapies and improved treatment options for patients.
Patients treated at minority-serving hospitals have only about two-thirds the odds of receiving palliative care compared to those receiving care at typical hospitals. The study found that racial and ethnic minorities are less likely to receive end-of-life palliative care than their counterparts, regardless of race or ethnicity.
Researchers found that terminally ill cancer patients who have hope, positivity and family support can live well during advanced stages. The study identified a five-phase iterative process involving struggling, accepting, living with the illness, sharing the experience, and reconstructing life.
Cardiff University researchers have identified a specific Fzd receptor called Fzd7 as the predominant Wnt receptor responsible for stem cell function in the stomach and intestine. Deleting this receptor makes gastric cells unable to divide and grow, providing a potential new therapeutic route for gastric cancers.
The SU2C Meg Vosburg T-Cell Lymphoma Dream Team is developing CAR-based immunotherapy strategies to target cancerous T cells without harming the immune system. The team aims to find a therapy that can improve outcomes in this patient population and make treatments more available.
Researchers at George Washington University Cancer Center have engineered a nanoimmunotherapy ensemble to increase the potency of immune checkpoint inhibitors in treating cancer. The goal is to convert 'cold' tumors into 'hot' tumors, which can be more responsive to immunotherapy.
A study of over 800 patients with laryngeal cancer found a significant risk of the disease associated with persistent sore throats combined with other symptoms. The research aims to improve early detection and treatment outcomes for cancer patients.
A new study found that extending medication time for varenicline to 24 weeks combined with 24 weeks of counseling sessions improves quitting success rates and reduces relapse risk in cancer patients. For those taking the medication as directed, quit rates increased significantly.
Researchers analyzed data from 622 cancer patients and found that those with tachycardia had a higher mortality rate compared to those without it. Tachycardia was a significant predictor of overall mortality regardless of cancer type, highlighting the need for co-management of heart and cancer conditions.
Researchers at MUSC identified targeting Sirt-1 as a promising approach to controlling Graft-VS-Host Disease (GVHD) in patients undergoing bone marrow transplants. This study showed that inhibiting Sirt-1 can suppress T cells leading to GVHD without affecting tumor relapse, offering new hope for improved patient outcomes.
A new recovery pathway has been implemented to reduce hospital stays after the Whipple operation by 15 days, allowing patients with pancreatic cancer to transition more quickly to the next phase of treatment. The study found that this accelerated care did not increase complication rates and improved patient outcomes.
The debate centers on renaming ultra-low risk cancers to avoid unnecessary investigations and treatments. Experts recommend recalibrating thresholds for cancer diagnosis to categorize very low risk cancers as benign, reducing anxiety and improving patient outcomes.
A Rutgers study has identified the NSD2 gene as a key indicator of prostate cancer's likelihood to spread. The gene's targeting could lead to early detection and longer patient survival rates.
A large study of cancer patients reveals a significant proportion are undiagnosed with acute and chronic hepatitis B and C. The findings suggest that universal screening for these viruses may be warranted to prevent life-threatening complications and improve treatment outcomes.
A recent study surveyed 450 oncologists in the US, revealing that most are unaware of how to treat patients with LGBTQ+ differences but are interested in learning more. The researchers recommend establishing protocols for treating LGBTQ cancer patients and providing education and training for physicians.
A new study published in the Journal of Clinical Oncology highlights gaps in attitudes, knowledge, and practices towards LGBTQ patients among oncologists. The research identified a need for education and training on LGBTQ-related issues to improve care for this patient population.
A study of over 8.6 million cancer patients found that white males, younger patients, and those with specific types of cancer were more likely to commit suicide. The researchers aim to identify high-risk patients to tailor treatments and develop survivorship programs.
Researchers at Osaka University found that mapping residual esophageal tumors can predict long-term prognosis and direct personalized treatment plans. The study identified four tumor remnant patterns, with specific associations to disease factors such as prognosis and metastasis risk.
A new SWOG Cancer Research Network study found that cancer patients with comorbidities such as hypertension or asthma are less likely to participate in clinical trials. The study suggests that allowing patients with manageable comorbidities to join trials could increase treatment opportunities for thousands of patients.
A new AI algorithm has been developed to analyze digital images of the cervix and identify precancerous changes, outperforming human experts in accuracy. The approach has the potential to transform cervical cancer screening, especially in areas with limited resources.
Researchers discovered a gene signature associated with treatment response and survival in patients with HPV-positive head and neck cancers. The biomarker distinguishes between two subgroups within HPV-positive patients, one with similar survival rates to HPV-negative cancers.
Researchers found that cigarette smoking was associated with poor response to cisplatin-based chemotherapy in muscle-invasive bladder cancer patients. Current smokers were also at a higher risk of cancer recurrence compared to former and never smokers, according to the study published in BJU International.
The BRCA Exchange aggregates data on thousands of inherited variants in the BRCA1 and BRCA2 genes to improve cancer prevention, screening, and intervention. The resource includes expert classifications of variants, providing information for clinicians and researchers.
Researchers have determined general population quality of life normative data for 15 individual countries, allowing for regional comparisons and valid QLQ-C30 score interpretation. National differences in quality of life scores were found, with respondents from Austria and the Netherlands reporting higher scores.
A new study published in CANCER found that suicide risk increases significantly in the first year following a cancer diagnosis, with the highest increase seen for pancreatic and lung cancers. The study's authors emphasize the importance of screening for suicide risk and providing social and emotional support to newly diagnosed patients.
A new study finds that genetic testing for breast cancer does not cause excessive anxiety, even with ambiguous results. Researchers surveyed 1,063 women and found that the type of test or result did not significantly impact worry levels.
Researchers are developing a breath test to detect cancer at an early stage by analyzing volatile organic compounds in the breath. The PAN Cancer trial aims to identify patterns of VOCs that could indicate the presence of different types of cancer.
Researchers developed two machine learning models to predict cancer patients' symptoms like depression, anxiety, and sleep disturbance. The models accurately predicted the severity of these symptoms throughout treatment, suggesting a potential improvement in quality of life for cancer patients.
A new study found that patients with stage IV ALK-positive lung cancer have a median overall survival of 6.8 years, significantly higher than the 2 percent five-year survival rate for all NSCLC patients. This optimistic outlook is attributed to targeted therapies and careful surveillance.
Medical University of South Carolina researchers found that advanced glycation end products (AGEs) can hamper response to tamoxifen therapy for ER-positive breast cancer patients. Lifestyle interventions, such as exercise and dietary counseling, may help reduce AGE levels and improve treatment outcomes.
Researchers from KAIST have identified novel pathways involving T immune cell exhaustion in liver cancer patients. The study provides evidence for designing optimal strategies for immune checkpoint blockades and offers a new path for customized medicine.
Researchers found a significant association between cancer development and an elevated risk of heart attack and stroke in the months leading up to the diagnosis. The risk was highest for patients with lung and colorectal cancers and those diagnosed with stage 3 or 4 disease, peaking in the month before diagnosis.
Researchers analyzed US population-based cancer registry data and found a significant increased risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after chemotherapy for most solid tumors. The risk was highest for certain types of cancer, such as lung, ovary, breast, and testis cancers.
A study by the University of Colorado Anschutz Medical Campus found that Facebook advertising can effectively reach rural communities with information and reminders about cancer screening. The EndCancer initiative resulted in a high engagement rate, with 96% of participants staying enrolled.
Researchers analyzed data from over 1,000 breast cancer patients and identified seven clusters of patients based on their immune evasion mechanisms. This study provides a better understanding of how breast cancer hides from the immune system, allowing oncologists to develop more personalized treatment options.
Researchers created a patient-specific tumor 'organoid' model to identify the most effective treatment for each tumor. The study successfully generated organoids for nine out of 12 patients, demonstrating the potential for personalized medicine.
A new study found that cancer patients, particularly those with blood-related cancers, have a significantly higher risk of developing shingles due to the virus reactivating later in life. New shingles vaccines offer great promise as a strategy to prevent shingles and its complications in cancer patients.
A study at Beth Israel Deaconess Medical Center found that mice infected with H. pylori bacteria and lacking claudin 18 developed precancerous cells and polyps. The loss of claudin 18 alone was enough to prompt precancerous cell development, indicating a new strategy to inhibit gastric cancer progression.
A recent study published in eLife found a strong relationship between copy number changes in genes and cancer patient outcomes. The researchers identified specific biomarkers that can determine a patient's prognosis, providing new hope for personalized cancer treatment.
Scientists identified that loss of two genes drives serrated colorectal cancer and found a combination treatment that has treated the cancer in mice. This discovery holds implications for patient care and may provide insights into the link between inflammatory bowel disease and colorectal cancer.
Researchers at McGill University Health Centre found a gene called EGFRvIII that changes the content of messages exchanged between cells, leading to aggressive brain cancer glioblastoma. This discovery holds promise for developing tests and tailored treatments for patients with glioblastoma.
A novel tool has been developed to identify genetic changes in Lynch syndrome genes associated with disease symptoms. The tool, combining laboratory test results with computer-based modeling and clinical data, achieves an accuracy of about 97 percent, making it suitable for clinical use.
A new study found that an ultrarestrictive opioid prescribing strategy was associated with fewer pills dispensed after surgery, without changes in postoperative pain scores or complications. The protocol reduced opioid pill dispensing by 72-85% for patients undergoing different types of surgery.